As such, in some studies, nausea induced by GLP-1RAs is linked to weight loss ( Pancreatic Adverse Events: Pancreatitis and Pancreatic Cancer Within years of the introduction of GLP-1RAs, these agents were linked to the occurrence of acute pancreatitis, and suggested to potentially cause pancreatic cancer ( While establishing (the absence of) a link with pancreatitis and pancreatic cancer in large clinical studies was one aspect in this field of research, others focused on animal studies and more mechanistic findings
Drugs referenced within the studies Tasks Iinvolved in the Studies All the reviewed works can be categorised into one of six main tasks: classification, extraction, normalisation, resource construction, pipeline development, and analysis
Our Experience At Rheumatologist OnCall, in the past two years, our patients have experienced: Remarkable drops in pain, morning stiffness (even with microdoses) Surge in energy, improved sleep, and confidence Steady, sustainable weight loss Reduced need for or the ability to taper steroids, DMARDs, and biologics For carefully selected patients, GLP-1 therapy has been truly life-changing
In clinical studies, patients lost up to 15-20% of their body weight* using certain branded GLP-1s